NCT01290042 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. Status COMPLETED Phase PHASE1
NCT01288053 Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01287897 A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy Status COMPLETED Phase PHASE2
NCT01277666 A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT01277289 Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease Status TERMINATED Phase PHASE3
NCT01276509 Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease Status COMPLETED Phase PHASE2
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut Status COMPLETED Phase PHASE1/PHASE2
NCT01266629 The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy Status UNKNOWN Phase N/A
NCT01258205 Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects Status COMPLETED Phase PHASE1
NCT01244386 Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease Status UNKNOWN Phase N/A
NCT01235689 Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01235325 The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients Status COMPLETED Phase PHASE4
NCT01233960 Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01224171 Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE3
NCT01215890 Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease Status COMPLETED Phase PHASE4
NCT01203631 Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE2